Demographic and clinicopathological characteristics of patients and the statistical significance of the associations of these data with piR-36741 and piR-36707 gene expressions of the patients.

Table 1: Demographic and clinicopathological characteristics of patients and the statistical significance of the associations of these data with piR-36741 and piR-36707 gene expressions of the patients.

			p value
		Patients (n = 19)	piR-36741	piR-36707
Gender	Male	9 (47.4%)	0.182	0.006
	Female	10 (52.6%)
Age	35-44	4 (21%)	0.093	0.306
	45-64	10 (52.7%)
	> 65	5 (26.3%)
TNM staging	Stage I	13 (68.4%)	0.01 (between stage I and II) < 0.001 (between stage I and IV)	0.037 (between stage I and IV) < 0.001 (between stage II and IV)
	Stage II	3 (15.8%)
	Stage III	1 (5.3%)
	Stage IV	2 (10.5%)
Fuhrman nuclear grade	Grade 2	13 (68.4%)	0.036 (between grade 2 and 4)	< 0.001 (between grade 2 and 4)
	Grade 3	2 (10.5%)
	Grade 4	4 (21.1%)
RBC count	Low	4 (21%)	0.042 (between low and normal RBC count)	0.06 (between low and normal RBC count)
	Normal	14 (73.7%)
	High	1 (5.3%)
RBC count	Low	4 (21%)	0.042 (between low and normal RBC count)	0.06 (between low and normal RBC count)
	Normal	14 (73.7%)
	High	1 (5.3%)
Hemoglobin count	Low	7 (36.8%)	0.08	< 0.001
	Normal	12 (63.2%)

(Abbreviations.TNM: Tumor Node Metastasis) (RBC count lower than 4 million/mm³ and hemoglobin count lower than 13 g/dl were considered as low).